Marinus Pharmaceuticals (MRNS) Short Interest Ratio & Short Volume → Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad) Free MRNS Stock Alerts $1.40 -0.02 (-1.06%) (As of 02:46 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Marinus Pharmaceuticals Short Interest DataCurrent Short Volume3,470,000 sharesPrevious Short Volume3,570,000 sharesChange Vs. Previous Month-2.80%Dollar Volume Sold Short$31.37 millionShort Interest Ratio / Days to Cover7.7Last Record DateMarch 31, 2024Outstanding Shares54,930,000 sharesPercentage of Shares Shorted6.32%Today's Trading Volume1,836,871 sharesAverage Trading Volume1,411,516 sharesToday's Volume Vs. Average130% Short Selling Marinus Pharmaceuticals ? Sign up to receive the latest short interest report for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRNS Short Interest Over TimeMRNS Days to Cover Over TimeMRNS Percentage of Float Shorted Over Time Ad Tips4TradersUncover this 2024 Hidden GemExclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today. Marinus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20243,470,000 shares $31.37 million -2.8%N/A7.7 $9.04 3/15/20243,570,000 shares $33.52 million +4.1%N/A8.2 $9.39 2/29/20243,430,000 shares $32.59 million -3.9%N/A7.9 $9.50 2/15/20243,570,000 shares $35.70 million -1.4%N/A9.1 $10.00 1/31/20243,620,000 shares $35.26 million -6.0%N/A8.8 $9.74 1/15/20243,850,000 shares $37.73 million -12.3%N/A8.8 $9.80 Get the Latest News and Ratings for MRNS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marinus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20234,390,000 shares $47.72 million +12.0%N/A10.1 $10.87 12/15/20233,920,000 shares $33.67 million -1.0%N/A8.7 $8.59 11/30/20233,960,000 shares $26.65 million -13.0%N/A8 $6.73 11/15/20234,550,000 shares $28.03 million +2.7%N/A8.1 $6.16 10/31/20234,430,000 shares $30.74 million +15.1%N/A6.6 $6.94 10/15/20233,850,000 shares $26.49 million +6.1%N/A5.8 $6.88 9/30/20233,630,000 shares $29.22 million -4.2%N/A5.4 $8.05 9/15/20233,790,000 shares $23.12 million +5.6%N/A5.3 $6.10 8/31/20233,590,000 shares $25.52 million +7.5%N/A4.3 $7.11 8/15/20233,340,000 shares $20.47 million +14.0%N/A4 $6.13 7/31/20232,930,000 shares $31.18 million -9.3%N/A3.5 $10.64 7/15/20233,230,000 shares $31.85 million +17.0%N/A3.7 $9.86 6/30/20232,760,000 shares $29.97 million +54.2%N/A3 $10.86 6/15/20231,790,000 shares $17.54 million +17.0%N/A2.1 $9.80 5/31/20231,530,000 shares $10.88 million -16.4%N/A2.2 $7.11 5/15/20231,830,000 shares $15.77 million +19.6%N/A2.9 $8.62 4/30/20231,530,000 shares $13.92 million -19.9%N/A2.7 $9.10 4/15/20231,910,000 shares $14.11 million +7.3%N/A3.8 $7.39 3/31/20231,780,000 shares $12.28 million +17.1%N/A3.8 $6.90 3/15/20231,520,000 shares $10.06 million +7.0%N/A3.5 $6.62 2/28/20231,420,000 shares $9.80 million +6.8%N/A3.6 $6.90 2/15/20231,330,000 shares $9.02 million +2.3%N/A3.6 $6.78 1/31/20231,300,000 shares $8.26 million -7.8%N/A3.1 $6.35 1/15/20231,410,000 shares $6.97 million +3.7%N/A3.8 $4.94 12/30/20221,360,000 shares $5.41 million +5.4%N/A4.2 $3.98 12/15/20221,290,000 shares $5.29 million +1.6%N/A4 $4.10 11/30/20221,270,000 shares $6.08 million -1.6%N/A4 $4.79 11/15/20221,290,000 shares $6.18 million -12.2%N/A4.6 $4.79 10/31/20221,470,000 shares $8.45 million +6.5%4.5%5.5 $5.75 10/15/20221,380,000 shares $7.40 million -5.5%4.3%6.3 $5.36 9/30/20221,460,000 shares $9.71 million +29.2%4.5%7 $6.65 9/15/20221,130,000 shares $7.55 million +3.7%3.5%4 $6.68 8/31/20221,090,000 shares $7.59 million +17.6%3.4%3.7 $6.96 8/15/2022927,200 shares $5.27 million -7.3%2.9%2.8 $5.68Uncover this 2024 Hidden Gem (Ad)Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today. MRNS Short Interest - Frequently Asked Questions What is Marinus Pharmaceuticals' current short interest? Short interest is the volume of Marinus Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 3,470,000 shares of MRNS short. Learn More on Marinus Pharmaceuticals' current short interest. What is a good short interest ratio for Marinus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRNS shares currently have a short interest ratio of 8.0. Learn More on Marinus Pharmaceuticals's short interest ratio. Which institutional investors are shorting Marinus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Marinus Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Marinus Pharmaceuticals' short interest increasing or decreasing? Marinus Pharmaceuticals saw a drop in short interest in March. As of March 31st, there was short interest totaling 3,470,000 shares, a drop of 2.8% from the previous total of 3,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Marinus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Marinus Pharmaceuticals: Kronos Bio, Inc. (1.69%), Equillium, Inc. (6.27%), Landos Biopharma, Inc. (0.17%), Lantern Pharma Inc. (5.33%), Celularity Inc. (3.94%), Immix Biopharma, Inc. (2.81%), Rallybio Co. (7.60%), Carisma Therapeutics, Inc. (8.17%), Eagle Pharmaceuticals, Inc. (10.59%), HCW Biologics Inc. (0.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Marinus Pharmaceuticals stock? Short selling MRNS is an investing strategy that aims to generate trading profit from Marinus Pharmaceuticals as its price is falling. MRNS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Marinus Pharmaceuticals? A short squeeze for Marinus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRNS, which in turn drives the price of the stock up even further. How often is Marinus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRNS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: KRON Short Interest EQ Short Interest LABP Short Interest LTRN Short Interest CELU Short Interest IMMX Short Interest RLYB Short Interest CARM Short Interest EGRX Short Interest HCWB Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRNS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm PressHow Biden has already won 2024Porter & Company